Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Aurinia Pharmaceuticals Q2 EPS $0.16 Beats $0.14 Estimate, Sales $70.01M Beat $64.25M Estimate

Author: Benzinga Newsdesk | July 31, 2025 05:00am
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.14 by 11.11 percent. This is a 1500 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $70.01 million which beat the analyst consensus estimate of $64.25 million by 8.97 percent. This is a 22.41 percent increase over sales of $57.19 million the same period last year.

Posted In: AUPH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist